|
|
40
|
|
|
5691F
|
|
|
ZOVIRAX 50MG/ML INJ (GSK/COL) ACYCLOVIR
|
|
|
ACYCLOVIR
|
|
|
ZOVIRAX
|
|
|
5X5ML
|
|
|
BQ
|
|
|
437.87
|
|
|
87.57
|
|
|
50MG/ML
|
|
|
INJECTION
|
|
|
0
|
|
|
VIAL
|
|
|
GSK
|
|
|
GLAXOSMITHKLINE
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
081832
|
|
|
NUCLEOSIDES AND NUCLEOTIDES
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ANTI-INFECTIVE AGENTS
|
|
|
|